Back

Associations of epicardial fat and markers of subclinical diastolic dysfunction in metabolic syndrome

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart (1) Metabolic Syndrome, Insulin, Insulin Resistance ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mrs Behnoush Gustafsson

Turku (Finland)

5 More presentations in this session

Presentation thumbnail
Association between the oxidative balance score and mortality in patients with metabolic syndrome
Professor J. Gao (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Early SGLT2i therapy in patients with T2DM and ACS results in reduction in cardiovascular and renal outcomes- a propensity score matched multi-model retrospective registry analysis
Doctor M. Shah (Hull, GB)
Abstract Slides Video
Presentation thumbnail
Dietary inflammatory index in progression and mortality risk of cardiovascular-kidney-metabolic syndrome: NHANES 1999-2018
Doctor Y. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The impact of microalbuminuria and proteinuria on cardiovascular outcomes in individuals with type 2 diabetes mellitus: a population-based, electronic health records study
Doctor M. Mohamed (London, GB)
Abstract Slides Video
Presentation thumbnail
Lower glomerular filtration rate is correlated with higher left heart remodeling in individuals with type 2 diabetes
Doctor N. Espinola-Zavaleta (Mexico City, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and the heart (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Epicardial adipose tissue and subclinical alterations in cardiac structure and function in early adulthood
thumbnail
Congress Presentation
Epicardial adipose tissue thickness as an early predictor of metabolic syndrome in young women with BMI <30
thumbnail
Congress Presentation
The epicardial adipose tissue volume is in patients with type 2 diabetes mellitus associated with a lowered myocardial perfusion reserve

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources